ORIGINAL ARTICLE
Open Access
Expanding Access to Injectable Contraception: Results From Pilot Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in 4 African Countries
Anna Stout, Siri Wood, George Barigye, Alain Kaboré, Daouda Siddo and Ida Ndione
Global Health: Science and Practice March 2018, 6(1):55-72; https://doi.org/10.9745/GHSP-D-17-00250
Anna Stout
aPATH, Seattle, WA, USA.
Siri Wood
aPATH, Seattle, WA, USA.
George Barigye
bPATH, Kampala, Uganda.
Alain Kaboré
cUNFPA Burkina Faso, Ouagadougou, Burkina Faso. Currently with PATH, Dakar, Senegal.
Daouda Siddo
dUNFPA Niger, Niamey, Niger.
Ida Ndione
ePATH, Dakar, Senegal.
Submit a Comment to This Article
Jump to comment:
No comments have been published for this article.
In this issue
Global Health: Science and Practice
Vol. 6, No. 1
March 21, 2018
Expanding Access to Injectable Contraception: Results From Pilot Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in 4 African Countries
Anna Stout, Siri Wood, George Barigye, Alain Kaboré, Daouda Siddo, Ida Ndione
Global Health: Science and Practice Mar 2018, 6 (1) 55-72; DOI: 10.9745/GHSP-D-17-00250
Expanding Access to Injectable Contraception: Results From Pilot Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in 4 African Countries
Anna Stout, Siri Wood, George Barigye, Alain Kaboré, Daouda Siddo, Ida Ndione
Global Health: Science and Practice Mar 2018, 6 (1) 55-72; DOI: 10.9745/GHSP-D-17-00250
Statistics from Altmetric.com
Jump to section
Related Articles
Cited By...
- What Have We Learned? Implementation of a Shared Learning Agenda and Access Strategy for the Hormonal Intrauterine Device
- Self-injected contraceptives: does the investment reflect womens preferences?
- What Distinguishes Women Who Choose to Self-Inject? A Prospective Cohort Study of Subcutaneous Depot Medroxyprogesterone Acetate Users in Ghana
- Introduction of Community-Based Provision of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in Benin: Programmatic Results
- Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) Injectable Contraception at Facility and Community Levels: Pilot Results From 4 Districts of Uganda
- The Coming-of-Age of Subcutaneous Injectable Contraception